Page 8 - Interested Persons News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(2) Regulatory News: Pherecydes Pharma (Paris:ALPHE) (FR0011651694 ALPHE), a biotechnology company specializing in precision phage therapy for the treatment of resistant and/or complicated bacterial infections, today announced that the United States Patent and Trademark Office (USPTO) has granted two patents for its anti-Pseudomonas Aeruginosa and Guy-Charles Fanneau de La Horie, CEO of Pherecydes Pharma, says: "We are very pleased that the USPTO has granted us these two new patents for our anti-Pseudomonas aeruginosa and anti-E. Coli phages. These two new patents in the world's leading he...

Resounding Success of Pherecydes Pharma's IPO on the Euronext Growth Market in Paris Offer oversubscribed 4 times, with global demand totaling €28.1 million Capital increase of approximately €8 million, after full exercise of the Extension Clause Trading in the Company's shares begins on February 5, 2021 (FR0011651694 ALPHE) Regulatory News: Pherecydes Pharma (Paris:ALPHE) (FR0011651694 ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today announces the resounding success of its initial public offering on...